Evidence map›Paper›PMID 39451615›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Comparing Different Methods for the Diagnosis of Liver Steatosis: What Are the Best Diagnostic Tools?

Sophie Chopinet, Olivier Lopez, Sophie Brustlein, Antoine Uzel, Anais Moyon, Isabelle Varlet, Laure Balasse, Frank Kober, Mickaël Bobot, Monique Bernard and 8 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nano-Enhanced Diets: Advancing Metabolic Dysfunction-Related Steatotic Liver Disease (MASLD) - A Review.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sophie ChopinetDepartment of Digestive Surgery and Liver Transplantation, Hôpital la Timone, AP-HM, 13005 Marseille, France.ORCID 0000-0002-5674-7280
Olivier LopezAix Marseille Université, LIIE, 13007 Marseille, France.
Sophie BrustleinAix Marseille Université, CERIMED, 13007 Marseille, France.
Antoine UzelINSA-Lyon, Université Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR5220, U1294, 69616 Lyon, France.
Anais MoyonC2VN, INSERM 1263 INRAE 1260, Aix-Marseille Université, 13007 Marseille, France.
Isabelle VarletAix-Marseille Université, CNRS, CRMBM, 13007 Marseille, France.ORCID 0000-0002-1711-7980
Laure BalasseAix Marseille Université, CERIMED, 13007 Marseille, France.
Frank KoberAix-Marseille Université, CNRS, CRMBM, 13007 Marseille, France.ORCID 0000-0002-7869-3615
Mickaël BobotAix Marseille Université, CERIMED, 13007 Marseille, France.ORCID 0000-0002-9451-0372
Monique BernardAix-Marseille Université, CNRS, CRMBM, 13007 Marseille, France.ORCID 0000-0002-3179-8698
Aurélie HaffnerDepartment of Anatomopathology, Hôpital la Timone, AP-HM, 13007 Marseille, France.
Michaël SdikaINSA-Lyon, Université Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR5220, U1294, 69616 Lyon, France.
Bruno MontcelINSA-Lyon, Université Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR5220, U1294, 69616 Lyon, France.ORCID 0000-0003-3352-9560
Benjamin GuilletAix Marseille Université, CERIMED, 13007 Marseille, France.ORCID 0000-0002-7578-6824
Vincent VidalAix Marseille Université, LIIE, 13007 Marseille, France.
Emilie GrégoireAix Marseille Université, LIIE, 13007 Marseille, France.
Jean HardwigsenDepartment of Digestive Surgery and Liver Transplantation, Hôpital la Timone, AP-HM, 13005 Marseille, France.
Pauline BrigeAix Marseille Université, LIIE, 13007 Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the ongoing organ shortage, marginal grafts with steatosis are more frequently used in liver transplantation, leading to higher occurrences of graft dysfunction. A histological analysis is the gold standard for the quantification of liver steatosis (LS), but has its drawbacks: it is an invasive method that varies from one pathologist to another and is not available in every hospital at the time of organ procurement. This study aimed to compare non-invasive diagnostic tools to a histological analysis for the quantification of liver steatosis.

methodsMale C57BL6J mice were fed with a methioninecholine-deficient (MCD) diet for 14 days or 28 days to induce LS, and were compared to a control group of animals fed with a normal diet. The following non-invasive techniques were performed and compared to the histological quantification of liver steatosis: magnetic resonance spectroscopy (MRS), CARS microscopy,

resultsAfter 28 days on the MCD diet, an evaluation of LS showed ≥30% macrovesicular steatosis. High correlations were found between the NIR-SG1 and the blinded pathologist analysis (R

conclusionsThe best-performing non-invasive methods for LS quantification are MRS, CARS microscopy, and the NIR-SG1. The NIR-SG1 is particularly appropriate for clinical practice and needs to be validated by clinical studies on liver grafts.

Indexed as

99mTc MIBICARS microscopyliver steatosisMCD dietMR spectroscopynear-infrared spectroscopy

Identifiers

PMID39451615
PMCPMC11506074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.